Human Pluripotent Stem Cell Facility (HPSCF)

The Ottawa Hospital, Ottawa, Ontario
What the facility does

Provide training, support and enable research with human embryonic and induced pluripotent stem cells

Area(s) of Expertise

Pluripotent stem cells are capable of differentiating into all the cells of the embryo proper and adult organism. Induced pluripotent stem cells (iPSCs) are created by reprogramming mature adult cells (such as skin cells). Pluripotent stem cells offer a unique opportunity to dissect early human development, generate models of disease, and develop cellular or drug therapeutics that target a disease or target specific patients with a disease (i.e. personalized medicine). Pluripotent stem cells are important tools in Regenerative/Translational/Personalized Medicine.

The Human Pluripotent Stem Cell Facility is multidimensional in its reach within the scientific community. As a facility we provide: 1) All the infrastructure necessary to work with and generated human pluripotent stem cell lines; 2) Training on how to work with human embryonic stem cells (hESCs)/induced pluripotent stem cells (iPSCs); 3) Troubleshooting resources for members of the community working with stem cells; 4) Tools for new and experienced investigators embarking on using stem cell models; 5) Contract work for researchers at the University of Ottawa, its affiliates, government agencies, and other academic and private institutions; 6) Host symposiums and workshops for trainee education; and 7) Provide letters of support, budgets, and collaborative grant writing upon request.

Research Services
  • Training on how to work with human embryonic stem cells (hESCs)/induced pluripotent stem cells (iPSCs) (harvesting, passaging, thawing and freezing)
  • Training for reprogramming (differentiation, characterization)
  • Perform as a service (cell culture, reprogramming, differentiation, characterization, CRISPR genome editing)
  • Fibroblast extraction and expansion
  • Teratoma injection and extraction
  • Protocol development
Sectors of Application
  • Healthcare and social services
  • Life sciences, pharmaceuticals and medical equipment



Tri-gas incubators

For culturing cells in normoxic and hypoxic conditions

Picking hoods

For manual removal of differentiated hESCs/iPSCs and isolation of clones


Control rate freezer

Neon transfection system

Electroporation transfection system used for episomal reprogramming and gene editing


DNA shearing device

Cellomics ThermoFisher Arrayscan VTI high-content screening system

Live cell imaging and high content analysis

Becton Dickinson (BD) LSRFortessa cell analyzer system

Flow cytometry

ProteinSimple NanoPro 1000

Proteomic analyses of small numbers of cells

Amnis ImageStream X multispectral imaging flow cytometer

High throughput fluorescence imaging of cells in suspension

  • DNA Genotek Inc.
  • Carleton University (Dr. Bruin)
  • National Research Council of Canada (NRC)
  • Health Canada
  • McGill University (Dr. Corinne Hoesli)
  • Ottawa Heart Institute (Dr. Ouimet)



Reprogramming progeria fibroblasts re-establishes a normal epigenetic landscape

Human Pluripotent Stem Cell-Derived TSC2 - Haploinsufficient Smooth Muscle Cells Recapitulate Features of Lymphangioleiomyomatosis

Metformin Preconditioning of Human Induced Pluripotent Stem Cell-Derived Neural Stem Cells Promotes Their Engraftment and Improves Post-Stroke Regeneration and Recovery

Engineering PTEN-L for Cell-Mediated Delivery

Human induced pluripotent stem cell-derived lung progenitor and alveolar epithelial cells attenuate hyperoxia-induced lung injury